Medicine Archives - Rapeawn.com

Lantheus acquires radiopharma CDMO Evergreen

The US radiopharmaceuticals giant Lantheus is snapping up the Contract Development and Manufacturing (CDMO) Evergreen Theragnostics as it expands its

Ethris reports positive phase 1 results for ETH47 mRNA asthma treatment

Munich-based biotechnology company Ethris has announced encouraging topline data from a phase 1 clinical trial evaluating its lead messenger RNA

Novo Nordisk reports 22% weight loss with amycretin

Novo Nordisk has reported weight loss effects of up to 22% in patients who received a weekly subcutaneous dose of

Manas AI launches with $24.6 million seed round

The round was led by the US venture capital (VC) firm General Catalyst Partners with participation from compatriot VC Greylock

Applying data to real-world challenges

Head of solution value at One2Treat, Émilie Barré shares her journey to date with Outsourcing-Pharma. Could you give us an

The largest pharma acquisitions of 2024

Compared to the previous years, 2024 has been a relatively slow year for mergers and acquisitions in the pharmaceutical space.

Arctic therapeutics secures funding for groundbreaking dementia and acne treatments

Arctic Therapeutics announced this week that it has raised €26.5 million, a sum bankrolled by investors including the European Innovation

Trial shows high-dose Wegovy can increase weight loss effects

Results from the STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects

BioCina and NovaCina join forces in merger

Australian contract development and manufacturing organizations (CDMOs), BioCina and NovaCina, have merged in a move to pool their biologic and

AI proving critical in clinical trial design

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the company’s goals

Spotlight on patient centricity in clinical trials

We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient

Medable Showcases AI-Powered Innovations at SCOPE 2025

Stakeholders across the clinical trials and digital health industry will be gathering next month in Orlando at the Summit for

Tech key to accelerating clinical trial outcomes

Ashley Davidson, vice president of sponsor and tech strategy at Advarra, discusses her outlook for this year’s edition of the

WCG’s outlook for SCOPE 2025

As pharmaceutical pipelines and R&D investments expand worldwide, the global market for clinical trials is projected to grow by almost

Patient Perspectives and Multidimensional Assessments

The evolution of clinical trials is being driven by an increased focus on patient perspectives and innovative statistical methodologies. Regulatory

Johnson & Johnson acquires Intra-Cellular Therapies in $14.6bn deal

Johnson & Johnson has entered an acquisition agreement with drug developer Intra-Cellular Therapies priced at $14.6bn, positioning the deal as

Scope Summit 2025 award finalists announced

As the Cambridge Healthtech Institute (CHI) celebrates its 16th annual Clinical Ops Executives (SCOPE) Summit in Orlando, Florida, USA, next

Anthem Biosciences plans IPO worth $397m

As India’s contract manufacturing and development organization (CDMO) is set to double in the next decade, Anthem Biosciences is planning

Verdiva Bio’s launch is backed by financing of over $410m

The company’s launch is backed by an oversubscribed Series A round of $411m co-led by Forbion and General Atlantic. RA

Denali’s ALS Drug DNL343 Misses Key Trial Endpoint

Denali Therapeutics has announced topline results from the phase 2/3 Healey ALS Platform Trial, which evaluated the effects of its

Orbis Medicines bags €90 million Series A

Orbis was founded in 2021 by the Seeds Investment team of Novo Holdings, the assets and wealth manager of the

Bremelanotide: Promising Diabetic Nephropathy Treatment

Palatin Technologies has announced topline results for the phase 2b Breakout study, which evaluated the effects of bremelanotide in patients

Gilead taps into Terray’s AI-based drug discovery

According to the terms of the deal, Gilead will select a set of drug targets and Terray will discover and

Brazil’s Nintx bags $10m for plant-based drugs

Founded by a team of scientists and healthcare specialists in 2021, Nintx harnesses compounds from Brazil’s world-famous plant ecosystems to

AbbVie acquires Nimble for oral peptides

AbbVie and Nimble Therapeutics have announced an acquisition deal in which AbbVie will gain ownership of the company’s pipeline of

General Inception acquires Enable Medicine

The company creator General Inception (GI) has acquired Enable Medicine to pool its know-how regarding drug development and the biotech

Noema Pharma Secures $147M to Advance CNS Disorder Treatments

Noema Pharma has announced an extension of its series B financing round, bringing the total raised up to $147 million

Eli Lilly expansion set to add 750 skilled jobs to Wisconsin site

Shortly after acquiring a manufacturing site in Wisconsin, Eli Lilly intends to expand it to boost its production of injectable

AbbVie set to file for FDA approval on tavapadon

Pharma company, AbbVie, reports that its D1/D5 partial agonist, tavapadon, has met the primary and secondary endpoints in a pivotal

PTC Therapeutics boosted by Novartis rights deal for Huntington’s program

PTC Therapeutics announced this week that it has made a deal with Novartis for global rights to its oral Huntington’s

Investment in radiopharmaceuticals is ramping up

Investment in radiopharmaceuticals is ramping up as big pharma shows a growing appetite for this promising drug modality. Radiopharmaceuticals see

Mitsubishi and Dewpoint team up to tackle ALS

The pharma arm of Mitsubishi Chemical Group has launched a collaboration with US-based Dewpoint Therapeutics to co-develop a preclinical-stage treatment

Körber absorbs Bähren to expand pharma packaging

The pharmaceutical business unit of the German giant Körber has snapped up the compatriot label and leaflet supplier Wilhelm Bähren

Novocure’s TTFields therapy boosts survival in pancreatic cancer

Swiss oncology specialist Novocure has announced positive topline results from the PANOVA-3 phase 3 clinical trial, which evaluated the use

Tech-driven solutions for patient access

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to travel to

Overcoming nonspecific binding challenges in PK assays

However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and best practices

Diabetes prevention – Eli Lilly’s Tirzepatide shows 23% weight loss

Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight prediabetic participants

Equity boost and partnership aim to accelerate GEMS platform’s efficiency

NVentures also participated in the company’s $200 million Series B last August. This strengthened collaboration is aimed at advancing Genesis’

AstraZeneca invests $3.5BN to boost US manufacturing power

With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is looking to

FDA grants orphan drug designation to CervoMed’s dementia drug

The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational small molecule

Portugal’s Hovione builds spray drying capacity in US and Ireland

Spray drying involves converting pharmaceutical liquid solutions into tiny droplets that are rapidly dried with hot gases such as nitrogen.

Phase 3 success for AstraZeneca prostate drug

AstraZeneca has reported positive results from the CAPItello-281 phase 3 trial, which evaluated Truqap (capivasertib) in combination with Johnson &

We’ve upgraded Outsourcing Pharma to give you more of what you love

What’s new at leading trade publication Outsourcing Pharma

Adragos Pharma snaps up Baccinex to expand CDMO network

Founded in Munich in 2020, Adragos’ global manufacturing sites were acquired from other players including Haupt Pharma Livron, LAW Pharma,

Decentralized clinical trials market expected to grow to $25BN

According to a recent report by Business Research Insights, the total size of the global decentralized clinical trials market was

C Ray Therapeutics $100M to improve RDC technology platform

C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark.

How eCOA/ePRO is transforming clinical trials

eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and sponsors. In

Promising phase 2 results for Eli Lilly’s Muvalaplin

Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events.

Chemistry passion to industry leadership

Now the Global market development manager at Phenomenex, she thrives on connecting insights with solutions, all while channeling the wisdom

From lab to leading biopharma innovation

Now leading the Biopharma product management team at Phenomenex, she brings a problem-solving mindset honed by a love of forensic

Samsung Biologics and European pharma company enter major manufacturing deal

The global contract development and manufacturing organization (CDMO), Samsung Biologics, announced this week that it has entered into a collaboration

Pfizer’s HYMPAVZI wins EU approval for hemophilia A and B care

The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab),

Drug-free pain relief for knee osteoarthritis

Sameer Sabir, CEO and co-founder of Brixton Biosciences, aims to revolutionize pain management. With Neural Ice, the company’s groundbreaking drug-free

Icotrokinra ‘best in class oral therapeutic for plaque psoriasis’

The phase 3 ICONIC-LEAD study showed that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was able to

Pfizer’s HYMPAVZI wins EU approval for hemophilia A and B care

The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab),

C Ray Therapeutics $100M to improve RDC technology platform

C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark.

Promising phase 2 results for Eli Lilly’s Muvalaplin

Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events.

Coronado’s CSO champions data-driven innovation in clinical trials

At the helm of Coronado’s scientific strategy, Professor Visser-Rogers envisions a data-driven future powered by innovative methodologies and emerging technologies.

Gifthealth partners with United Digestive

Gifthealth has announced a strategic partnership with United Digestive, a leading practice management organization for gastroenterology. This is to enhance

Patients prefer telehealth for clinical trials, survey shows

Conducted with 136 US-based participants across multiple health conditions, the survey found that 63% said they would be more likely

AI-driven Medable Studio speeds digital trial startups

Medable, a provider of clinical development technology, has announced a collaboration with Google Cloud to bring its decentralized clinical trial

Overcoming nonspecific binding challenges in PK assays

However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and best practices

Equity boost and partnership aim to accelerate GEMS platform’s efficiency

This forms part of an expanded partnership to enhance Genesis’ AI-powered drug discovery platform, GEMS (Genesis Exploration of Molecular Space).

Diabetes prevention – Eli Lilly’s Tirzepatide shows 23% weight loss

Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight prediabetic participants

AstraZeneca invests $3.5BN to boost US manufacturing power

With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is looking to

Tech-driven solutions for patient access

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to travel to

Decentralized clinical trials market expected to grow to $25BN

According to a recent report by Business Research Insights, the total size of the global decentralized clinical trials market was

GHO and Ampersand acquire CDMO Avid Bioservices for $1.1 billion

Under the terms of the merger agreement, Avid Bioservices will be acquired by funds managed by GHO and Ampersand in

Merck, Abbisko’s oral drug aces phase 3 for rare tumors

According to the topline results, a total of 54% of patients given the treatment saw their tumors shrink compared to

Dexter Tjoa on Tjoapack’s journey and future in packaging

CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced technologies for patient safety,

Axonis raises $115 million to treat epilepsy

Epilepsy is one of the most common neurological conditions in the world, with around 50 million people with the condition.

Abzena unveils cell Line and ADC innovations at CPHI 2024

By offering comprehensive, integrated solutions, Abzena aims to streamline drug development processes and minimize risks for customers, helping to accelerate

Middle School MD fosters youth interest in medical careers

The Palomar Health Foundation recently completed its third annual Middle School Medical Discoveries (Middle School MD) program, engaging local youth

Novo Nordisk signs $285 million deal for a once-monthly Wegovy

Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license to its TransCon technology platform for the development, manufacturing and

Senhwa Biosciences starts trial of drug for rare cancers in children

Silmitasertib, also known as CX-4945, was originally developed by Cylene Pharmaceuticals, a San Diego-based biotech that ceased operations in 2013.

Veeva’s Tim Davis on overcoming eCOA deployment challenges

Tim Davis, vice president of strategy at Veeva eCOA, had a conversation with Outsourcing Pharma’s senior editor, Liza Laws, and

MD Anderson investment supports groundbreaking cancer therapies

Starget Pharma, an Israeli startup developing AI-powered precision therapies for difficult-to-treat cancers, has secured a $5.1 million investment from MD

AI-driven outreach boosts therapy start, adherence rates

A new case study from AllazoHealth demonstrates that a top 10 rare disease pharmaceutical company experienced a 10.4% increase in

Novo Nordisk study – semaglutide reduces hospital admissions

Novo Nordisk has released data from the SELECT phase 3 trial showing that a 2.4 mg dose of semaglutide reduced

First-line leukemia therapy granted accelerated approval by FDA

Novartis’ Scemblix (asciminib) has received accelerated approval by the US FDA as a treatment for adult patients with newly diagnosed

Labguru ELN integration enhances Thermo Fisher LIMS capabilities

This integration aims to create a unified lab management experience, offering scientists enhanced data traceability, security, and streamlined workflows across

Vicky Marriott on leading with empathy in science and statistics

In an exclusive interview, Vicky shares insights on her career, the challenges she faced, and her passion for inspiring the

Enhancing pharma manufacturing with digital twin technology

From reducing operational costs to enhancing patient outcomes, Stevanato Group is at the forefront of digital transformation in pharma. Digital

GLP-1 market heats up as companies vie for next-gen obesity drugs

Since the FDA approval of Novo Nordisk’s Wegovy as a treatment for chronic weight management in 2021, followed by the

Axonis raises $115 million to treat epilepsy

Epilepsy is one of the most common neurological conditions in the world, with around 50 million people with the condition.

Anu Codaty’s path to biotech leadership

With a background spanning biotech and executive roles at Medtronic, Anu brings a unique blend of resilience, collaboration, and strategic

NovAliX and Bruker forge alliance to boost drug discovery

This alliance marks a shift in biopharma R&D, with the launch of the Biophysics Institute for Biomedical Research (IBRB), offering

Rentschler Biopharma to boost production with new buffer media station

Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) will be increasing its production at its headquarters in Laupheim

GSK beefs up US manufacturing with $800 million

GSK is one of the world’s biggest pharmaceutical companies with products ranging from the shingles vaccine Shingrix and the HIV

Merck acquires Modifi Biosciences in $1.3B cancer drug deal

Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for $30 million

Merck acquires Modifi Biosciences in $1.3B cancer drug deal

Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for $30 million

NorthStar launches radiopharmaceutical CDMO

Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as antibodies. These

NorthStar launches radiopharmaceutical CDMO

Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as antibodies. These

Donanemab Alzheimer’s drug approved by MHRA, rejected by NICE

A new Alzheimer’s treatment, donanemab, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), but a draft

Boston biotech secures funds to advance depression, anxiety drug

Seaport has developed a platform called Glyph designed to enhance efficacy and reduce the side effects of potential drug candidates.

PTC Therapeutics DMD drug misses regulatory hurdle

The EU first gave Translarna a conditional marketing authorization in 2014 for the treatment of DMD, a progressive condition that

Women in Science – SCIEX Rebekah Sayers

Find out all about her intriguing journey to where she is now in her role as marketing manager within small

Acquisition adds late-stage drug candidate with blockbuster potential

Lundbeck and Longboard Pharmaceuticals have announced an agreement for the Danish pharmaceutical company to acquire all outstanding shares of Longboard,

The industry is opening up to techbio – panel highlights

Techbio is a field where the computational expertise of the tech sector and the biological know-how of the biotech sector

Jane Koo’s role in advancing cancer therapies at CTMC

With a career spanning monoclonal antibodies and now cell therapies, she expertly navigates complex regulatory landscapes to bring life-changing treatments

Corden Phama – staying on top of manufacturing trends

Outsourcing Pharma caught up with experts from the global CDMO, CordenPharma, to learn how they maintain their competitive edge. Brittany

Sanofi halts Denali’s MS drug trial after phase 2 failure

The K2 trial tested oditrasertib’s safety and ability to reduce the blood levels of neurofilament light chain, a biomarker of

Precision dosing expert Sharmeen Roy

With a background in pharmacy and specialized pediatric care, she now bridges bioinformatics with practical, user-friendly tools, empowering clinicians to

From researcher to market leader at SCIEX

Now a global market development manager, she plays a pivotal role in shaping solutions for food safety and environmental protection.

Sequentia Biotech bags €10m for omics products

Sequentia will use the round winnings to speed up the market introduction of its cloud-based and microbiome-focused healthcare software MICK

The impact of AI technology in pharmacovigilance

Eric Prugh is the chief product officer at Authenticx, a US-based company that recently launched an AI solution to detect

Enzene targets cost savings and efficiency

The significant advantages it offers include: Large reduction in COGS: By 2025, EnzeneX 2.0 expects to produce 40 kg/1000 L

SGD Pharma to showcase new glass packaging solutions at CPHI 2024

These siliconized vials are designed to protect sensitive, aggressive, and viscous drug products by reducing interactions with the glass and

FDA compliance and AI drive growth for Quotient

He will also be explaining how the company is expanding its Translational Pharmaceutics platform into new therapeutic areas like mRNA,

Evaxion AI platform identifies cancer vaccine targets in trials

Danish techbio company Evaxion Biotech has published results showing the outcome of three clinical trials comparing the prediction scores of

AstraZeneca strikes $2 billion deal with CSPC

Dyslipidemia, a condition involving unhealthy levels of cholesterols and other fats in the blood, is a major risk factor in

FDA clearance to start clinical trials with new obesity drug

Antag Therapeutics has announced that the FDA has accepted the investigational new drug (IND) application for its lead drug candidate,

Will AI live up to its promise and how will it impact global health?

One area it is thriving is pharmaceuticals as it is being used to bring drugs to market faster than ever

How will the Biosecure Act impact the pharma industry?

But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any

Third-generation lung cancer therapy commercialized

Innovent Biologics and Jiangsu Aosaikang Pharmaceutical (Ask Pharm) have announced a strategic collaboration regarding limertinib, a third-generation epidermal growth factor

Recipharm bolsters global production facilities

One of Recipharm’s main aims is the expansion of its oral solid dosage and sterile fill & finish services in

Symbiosis unveils expanded facility at CPHI Milan 2024

The event provides a great platform for the company to present its newest addition—a 20,000 sq ft facility in Stirling,

Adragos Pharma and the evolving world of outsourcing

We also delve into the latest trends, the rise of AI and the increasing focus on sustainability. How has the

Ardena expands bioanalytical and GMP services

The company explains attendees will gain insight into how Ardena’s innovations can streamline drug development for advanced therapies, particularly in

Stevanato to launch Vertiva 10mL on-body system at CPHI 2024

The company says this new platform is specifically designed to administer large-volume injectable therapies, including highly viscous biological drugs, making

SK pharmteco invests $260M in small molecules

The expansion involves setting up a new facility, which is planned to begin operations in late 2026. The facility, which

Women in Science – SCIEX Rebekah Sayers

Find out all about her intriguing journey to where she is now in her role as marketing manager within small

Optimizing patient recruitment for faster clinical trials

The success of these trials hinges on finding and enrolling the right patients in a timely manner. Eben Scanlon, chief

LoQus23 raises £35M to advance Huntington’s disease therapy

UK-based company LoQus23 Therapeutics has announced the closing of a £35 million series A round to advance its pipeline of

An Interview with Tim Martin of Yseop

In an insightful interview, Tim Martin, vice president, product, at Yseop, discusses the company’s recent advancements, notable collaborations, and the

How does Leal Health’s GenAI transform cancer patient care?

This innovation is poised to transform patient access to cancer care by leveraging advanced AI capabilities to provide personalized treatment

How is wearable tech enhancing sleep tracking in clinical trials?

Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose Wearable Digital

Tyra Biosciences announces proof of concept data in hypochondroplasia

Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate, TYRA-300, in

Vox Pop Pharma – where will AI be in five years?

Industry leaders give their takes on what else is in store for AI-based tools in the pharma space. AI-powered algorithms

CEO discusses hormone-free male birth control development

Bakshi shares the innovative approach of YCT-529, the results of their Phase 1a study, and the anticipated impact on reducing

Unlocking innovation: Women in Science

In this interview, she shares insights into her role, personal journey, challenges faced, and advice for aspiring women in science.

Barriers to opioid treatment access in the US

This Q&A with Sheeba Ibidunni, public health expert and the VP of operations at Sonara Health explores the socio-economic factors fuelling

Unveiling a key player in ovarian cancer survival

The initiative seeks to understand the crucial role of the omentum, a lesser-known yet vital organ in cancer treatment and

dsm-firmenich unveils advanced CBD drug product intermediate

The IP-protected CBD intermediate brings superior functionality allowing for a higher drug loading compared to currently commercially available products, paving

Women in Science – Vector Labs’ Pam James

With a lot of familial inspiration, an early love of science developed for Pam James, here we find out how

Eli Lilly enters $140M partnership with Radionetics Oncology

Eli Lilly has entered a strategic partnership with Radionetics Oncology, a biotechnology company focusing on the discovery and development of

CatSci acquires Reach Separations to offer chromatography services

The deal was supported by Keensight Capital, a private equity manager focusing on pan-European investments in the technology and healthcare

Tyra Biosciences announces proof of concept data in hypochondroplasia

Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate, TYRA-300, in

How does the FDA’s Accelerated Approval Program impact patients?

Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law, and regulatory

How is wearable tech enhancing sleep tracking in clinical trials?

Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose Wearable Digital

Esteve invests €100 million in Spanish API manufacturing muscle

The construction project will be financed until 2026 by a €100 million ($108 million) investment by the company. The facilities,

ALS treatment slows down disease progression by 36%

Results from the PARADIGM clinical trial have revealed that PrimeC, a treatment being developed by NeuroSense Therapeutics, was able to

Mainz Biomed’s cancer stool test takes on liquid biopsies

In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal cancer

Revolutionizing clinical trials: Yonalink’s game-changing tech

YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior editor, Liza

The evolution of personalized medicine for reproductive health

Also known as precision medicine, this kind of individualized treatment is designed specifically for the patient and has revolutionized cancer

The pharma industry’s commitment to sustainability

These efforts are driven by the need for transparency, compliance, and sustainability in response to pressures from stakeholders, including investors,

FDA greenlights Verona’s game-changing COPD drug Ohtuvayre

This groundbreaking approval is expected to transform the market for patients suffering from moderate to severe exacerbations, particularly those with

The top 5 emerging startups fuelling drug discovery with AI

Check out five upcoming AI players attracting investor attention for their potential to speed up drug discovery. Drug discovery is

ELRIG UK & The Protein Society host drug discovery conference

This collaboration aims to unite experts from various fields to explore how emerging protein science can address the challenges in

Revolutionizing clinical trials: Yonalink’s game-changing tech

YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior editor, Liza

Will Novo Nordisk’s $4.1BN US investment transform drug manufacturing?

This expansion, one of the largest in the company’s history, aims to enhance the production of injectable treatments for obesity

How does the FDA’s Accelerated Approval Program impact patients?

Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law, and regulatory

Sonara Health’s innovative app enhancing access to methadone treatment

With his background in psychiatry, Michael observed the daily struggles of patients in Opioid Treatment Programs and developed Sonara to

DSP Expansion Adds 200,000 sq.ft. to Boost R&D Capacity

The expansion will introduce 200,000 sq. ft. of additional space, addressing the growing demand for Grade-A facilities amid a rising

CluePoints’ growth investment from EQT: What’s next?

CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The

EMA’s new clinical trials guideline

This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023.

Deep dive – why did IQVIA launch a participant payments service?

IQVIA recognized the intricate challenges associated with participant payments in clinical trials, which often involve cumbersome processes and multiple vendors,

Mainz Biomed’s cancer stool test takes on liquid biopsies

In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal cancer

How are AI and real-world data speeding up drug development?

The panel featured Ariel Berger, executive director of integrated solutions and real-world evidence at Evidera; John Van Hoy, executive director

Is behavioral science key to patient-focused drug development?

Last year, Astellas Pharma established a behavioral science consortium to perform research aimed at better understanding what matters to patients

How will Cellibre’s $2M NIH grant revolutionize pharma production?

This first-of-its-kind phase 2 grant will expedite the commercialization of cannabinoid ingredient production via precision fermentation. The funding aims to

uMotif revolutionizing clinical trials with innovative eCOA solutions

However, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two decades ago,

Lokavant unveils AI solution for clinical trial optimization at DIA

Spectrum supports study teams by providing real-time predictions and control over trial timelines and costs, ensuring successful trials in today’s

How does genetic polymorphism affect Alzheimer’s treatments?

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active

What are the challenges in signal management in pharmacovigilance?

The conversation delves into the complexities of signal management in the PV landscape, highlighting recent advancements and the challenges faced

CluePoints’ growth investment from EQT: What’s next?

CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The

EMA’s new clinical trials guideline

This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023.

How will Thermo Fisher’s new EU Facility impact trials?

This expansion of Thermo Fisher’s clinical trial network in Europe will help foster global clinical trial innovation and provide biorepository

How does genetic polymorphism affect Alzheimer’s treatments?

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active

Combogesic IV – a new era of opioid-free pain relief medication?

This new medication, approved by the US FDA in October 2023, combines 1,000 mg of acetaminophen and 300 mg of

Lokavant unveils AI solution for clinical trial optimization at DIA

Spectrum supports study teams by providing real-time predictions and control over trial timelines and costs, ensuring successful trials in today’s

How does genetic polymorphism affect Alzheimer’s treatments?

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active

Systech unveils game-changing turnkey solution for pharma rework and aggregation

In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and rework solution

uMotif revolutionizing clinical trials with innovative eCOA solutions

However, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two decades ago,

Creative Qinesca unveiled at DIA – a game changer

Promising to redefine the landscape with its latest solutions, the company hopes to take center stage, offering advancements in data

GiftHealth’s vow to enhance patient outcomes

John Romano, president, and co-founder, shares exclusive insights into how these innovations are set to tackle industry challenges and enhance

how CluePoints is transforming research

This was to discuss what they describe as the groundbreaking impact of their Sub-population Optimization & Modeling Solution (SOMS). This

path forward is giving sites their own log-in credentials

Advarra is set to reveal solutions tailored to address current challenges in the pharmaceutical and healthcare industries. With the results

Lokavant unveils AI feasibility solution at DIA 2024

This innovative technology allows study teams to predict, optimize, and control trial timelines and costs in real-time, enabling iterative feasibility

A year of innovation: Roquette’s US center milestone

The center, envisioned as a hub for groundbreaking research and development in pharmaceutical sciences, has thus far successfully lived up

Is Stardog AI the cure for pharma batch delays?

Enter Stardog, an AI and data startup at the forefront of revolutionizing how drugs are brought to market. As pharmaceutical

FDA and CluePoints agreement boosting clinical data quality

FDA and its stakeholders have a vested interest in ensuring the integrity of clinical trial data and the safety of

Enzene Bioscience’s creative approach to biosimilars

He says the strategic expansion into continuous manufacturing facilities aims to revolutionize the accessibility and affordability of life-saving medicines. LL:

Diane Lacroix on Clinical Trials Day

Diane shares her expert insights on how creative data solutions are transforming the landscape of clinical research, enhancing efficiency, and

Positive CHMP opinion for Mirum’s Livmarli in PFIC

This endorsement comes from the phase 3 March study showing a highly significant reduction in pruritus severity compared to placebo

Shionogi expands infectious disease R&D to the US

The big announcement was made at the BIO International Convention, where top policy and health leaders gathered to discuss the

Uncovering the talent pool of AI in Montreal at Mila

Established in the 1990s by a group of professors including the renowned Yoshua Bengio, and Laurent Tillement, OSP was delighted

Revolutionizing drug development: AI’s game-changing potential

Christine Allen, a veteran with 25 years in drug formulation, is at the forefront of this breakthrough. She says Intrepid

Greenphire wins big at the 2024 MedTech Breakthrough Award

The company says its mission is geared towards enhancing clinical research site performance and participant satisfaction. This prestigious accolade recognizes

UK’s Celadon shipping cannabis-based medicine to the US

Following the signing of an introductory sales contract with a long-established American business, Celadon has successfully shipped two different medical

Women in Science – this week Orla Cussen

Coming from Donegal in the northwest of Ireland, where there isn’t much industry to a more than 20 years supporting

biggest psychiatric breakthrough in 40 years

Cybin is driven by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches – developing differentiated next-generation psychedelic therapeutics

biggest psychiatric breakthrough in 40 years

Cybin is driven by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches – developing differentiated next-generation psychedelic therapeutics

Asahi Kasei’s $1.1 billion power move

This strategic acquisition, valued at approximately SEK 11.8 billion (around $1.1 billion), aims to make Calliditas a wholly owned subsidiary,

how can pharma companies fight antimicrobial resistance?

According to the report, the race to create antibiotics and antifungals to conquer superbugs is falling perilously short, which the

Bicycle Therapeutics balance sheet boosted by $555M

The recent financing boosts Bicycle Therapeutics’ balance sheet, bringing the pro forma cash position to approximately $1 billion. This financial

Atropos funding surge enhancing AI in healthcare

This funding surge comes as the company continues to advance the application of generative AI through its platform, Geneva OS.

Swixx Biopharma creating new breed of global pharma partners

It has achieved this with the acquisition of Pharma Consulting Group S.A., the holding company of Laboratorios Biopas SA. This

Elinzanetant shows significant reduction in menopausal hot flashes

Detailed results from studies Oasis 1 and 2 will be showcased at the 2024 ACOG Annual Clinical & Scientific Meeting

How has geopolitical tension created problems for life sciences?

She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare, law, and